Holodiag joins Icrom Srl Group
Specific topics
10 septembre 2024
❗ BREAKING NEWS ❗
🤝 We are glad to announce that Holodiag has just joined Icrom Srl Group, an Italian API CDMO specialized in development and GMP manufacturing of potent and non-potent Active Ingredients with over 50 years of experience.
The acquisition of Holodiag is aligned with Icrom Srl Group strategy to become a global leader CDMO for the innovative as well as for the generic pharma space.
For Holodiag, it will bring a series of synergies and pool resources with a significant growth in size and capabilities.
🤝 Dr.Pierric Marchand remains General Manager
Dr. Pierric Marchand, GM of Holodiag (on the left) and Pierfrancesco Morosini, President of Icrom Group (on the right)